<DOC>
	<DOCNO>NCT00948194</DOCNO>
	<brief_summary>In study , researcher propose investigate efficacy inhale nitric oxide prevent ischemia-reperfusion ( I/R ) hepatocyte injury patient receive extend donor criterion ( EDC ) liver graft base change proteomic metabolomic marker follow revascularization donor graft . In review literature , uniform extend criterion donor classification exists . The characteristic associate liver graft failure appear cold ischemia time great 10 hour , warm ischemia time great 40 minute , donor age &gt; 55 year age , donor hospitalization &gt; 5 day , donation cardiac death ( DCD ) graft , split graft . The researcher exclude warm ischemia time impossible predict prior transplantation . Any donor meeting least one criterion classify EDC donor . Hypothesis 1 : Inhaled nitric oxide improve overall outcome liver recipient EDC liver transplantation - Suppression oxidative injury improve graft function postoperatively measure International Normalized Ratio ( INR ) bilirubin , transaminase , duration hospital stay . Hypothesis 2 : The mechanism therapeutic efficacy inhale nitric oxide base reduction post-reperfusion oxidative injury readily measure detectable change protein metabolic profile plasma patient treat inhaled-NO - Nuclear Magnetic Resonance ( NMR ) -based metabolic marker ( xanthine end-products , lactate , hepatic osmolytes ) consistent acute liver injury decrease NO-treated recipient . - Protein marker reperfusion injury ( argininosuccinate synthase ( ASS ) estrogen sulfotransferase ( EST-1 ) great plasma patient treat inhaled-NO - Reduced oxidative injury reflect decrease number mitochondrial peroxiredoxins isoforms number oxidize NO-treated liver recipient .</brief_summary>
	<brief_title>Effect Nitric Oxide ( NO ) Ischemic/Reperfusion Injury During Extended Donor Criteria ( EDC ) Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Age 18 69 year age moderate severe liver disease ( MELD score 22 30 ) receiving extend donor criterion liver graft undergo multiorgan transplant 70 year old diagnose hepatocarcinoma diagnose either hepatopulmonary syndrome pulmonary hypertension pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Extended Donor Criteria</keyword>
</DOC>